FEASIBILITY STUDY ON USING SOLAR PANELS AT A PHARMACEUTICAL PLANT IN THE MIDDLE EAST

Introduction: The study evaluates the feasibility of integrating solar energy into a pharmaceutical plant in the Middle East, considering the region’s high solar radiation levels, energy demands, and sustainability goals. With rising electricity costs and increasing environmental regulations, solar power presents a viable alternative to conventional energy sources. Methods: The analysis is based on a combination of global case studies, technical feasibility assessments, and economic evaluations. Data on solar radiation, panel efficiency, cost structures, and grid integration were examined. Additionally, financial models were developed to assess investment costs, return on investment (ROI), and payback periods. Results: The findings indicate that implementing solar panels can reduce energy costs by 40-60%, with an estimated payback period of 4.2–7.5 years. Grid-tied and hybrid solar energy systems offer significant financial benefits, with government incentives further improving cost-effectiveness. Key challenges include initial capital investment, energy intermittency, and maintenance in harsh climatic conditions. Discussion: Despite initial investment barriers, solar energy adoption in pharmaceutical plants is a strategic long-term solution, ensuring cost savings, energy security, and regulatory compliance. Advances in solar panel technology, battery storage, and AI-driven energy management will further enhance efficiency and reliability. A phased implementation approach, starting with rooftop solar installations and expanding to full-scale solar farms, is recommended to maximize benefits.